Podnos Yale
Chief Medical Officer
Podnos Yale has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Jul 17, 2026.
On the most recent filing, Podnos Yale is listed as Chief Medical Officer at Oncology Institute, Inc. Inside the rolling window, Podnos Yale reported no open-market purchases and 2 open-market sales totaling $276K in TOI. The largest disclosed transaction in the window is a sale of 23,452 TOI shares on Jul 14, 2026, worth $150K.
Companies traded
Other insiders at TOI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$276K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Podnos Yale made?
Podnos Yale has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.
Which companies does Podnos Yale trade?
Podnos Yale has filed SEC Form 4 disclosures for 1 company, including TOI.
When was Podnos Yale's most recent SEC Form 4 filing?
Podnos Yale's most recent SEC Form 4 filing on Tracefour is dated Jul 17, 2026.
What is Podnos Yale's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Podnos Yale is listed as Chief Medical Officer.
What is Podnos Yale's total buy and sell value in the current window?
Inside the rolling retention window, Podnos Yale bought $0 and sold $276K based on SEC Form 4 filings.
What was Podnos Yale's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 23,452 TOI shares on 2026-07-14, worth $150K, per SEC Form 4 filings.